Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

727 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of collected outcome measures in axial spondyloarthritis in daily-care rheumatology settings: the experience of the RHEVER network.
Che H, Etcheto A, Dernis E, Nataf H, Boumier P, Breuillard P, Durandin-Truffinet M, Fechtenbaum J, Gaud-Listrat V, Giraud B, Hudry C, Labatide-Alanore S, Le Devic P, Le Goux P, Lebrun A, Maheu E, Moura B, Nguyen M, Sacchi A, Ayral X, Blanchais A, Neveu S, Dougados M, Moltó A. Che H, et al. Among authors: sacchi a. Clin Exp Rheumatol. 2015 Nov-Dec;33(6):851-7. Epub 2015 Sep 28. Clin Exp Rheumatol. 2015. PMID: 26411931
Adherence to and patient's knowledge of self-management of subcutaneous biologic therapy in chronic inflammatory rheumatic diseases: results of a multicentre cross-sectional study.
Gaud-Listrat V, Lopez-Medina C, Hudry C, Nguyen M, Lebrun-Foisnet A, Sacchi A, Labatide Alanore S, Dernis E, Le Devic P, Fechtenbaum J, Richard-Miceli C, Le Goux P, Dadoun S, Moltό A, Blanchais-Behr A, Neveu S, Benhamou M, Giraud B, Roux C, Dougados M; RHEVER network (Hospital and City in Rheumatology Network). Gaud-Listrat V, et al. Among authors: sacchi a. Clin Exp Rheumatol. 2022 May;40(5):928-935. doi: 10.55563/clinexprheumatol/slk3yz. Epub 2021 May 28. Clin Exp Rheumatol. 2022. PMID: 34128794 Free article.
Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients.
Gossec L, Salejan F, Nataf H, Nguyen M, Gaud-Listrat V, Hudry C, Breuillard P, Dernis E, Boumier P, Durandin-Truffinet M, Fannius J, Fechtenbaum J, Izou-Fouillot MA, Labatide-Alanore S, Lebrun A, LeDevic P, LeGoux P, Sacchi A, Salliot C, Sparsa L, d'André FL, Dougados M; RHEVER Rheumatology Network. Gossec L, et al. Among authors: sacchi a. Arthritis Care Res (Hoboken). 2013 May;65(5):712-7. doi: 10.1002/acr.21935. Arthritis Care Res (Hoboken). 2013. PMID: 23589412 Free article.
Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study.
Toussirot E, Marotte H, Mulleman D, Cormier G, Coury F, Gaudin P, Dernis E, Bonnet C, Damade R, Grauer JL, Abdesselam TA, Guillibert-Karras C, Lioté F, Hilliquin P, Sacchi A, Wendling D, Le Goff B, Puyraveau M, Dumoulin G. Toussirot E, et al. Among authors: sacchi a. Arthritis Res Ther. 2020 Sep 29;22(1):224. doi: 10.1186/s13075-020-02297-7. Arthritis Res Ther. 2020. PMID: 32993784 Free PMC article.
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.
Tubach F, Salmon D, Ravaud P, Allanore Y, Goupille P, Bréban M, Pallot-Prades B, Pouplin S, Sacchi A, Chichemanian RM, Bretagne S, Emilie D, Lemann M, Lortholary O, Mariette X; Research Axed on Tolerance of Biotherapies Group. Tubach F, et al. Among authors: sacchi a. Arthritis Rheum. 2009 Jul;60(7):1884-94. doi: 10.1002/art.24632. Arthritis Rheum. 2009. PMID: 19565495 Free PMC article.
Innate and SARS-CoV-2 specific adaptive immune response kinetic in neutralizing monoclonal antibody successfully treated COVID-19 patients.
Casetti R, Sacchi A, Mazzotta V, Cristofanelli F, Grassi G, Gili S, Cimini E, Notari S, Bordoni V, Mastrorosa I, Giancola ML, Vergori A, Tempestilli M, Vita S, Mariotti D, Rosati S, Lalle E, Meschi S, Colavita F, Garbuglia AR, Girardi E, Nicastri E, Antinori A, Agrati C. Casetti R, et al. Among authors: sacchi a. Int Immunopharmacol. 2025 Jan 19;148:113934. doi: 10.1016/j.intimp.2024.113934. Online ahead of print. Int Immunopharmacol. 2025. PMID: 39832460
727 results